Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]

DRUG3 trials

Sponsors

Ohio State University, Lifespan, Duke University

Conditions

HCVHEPATITIS C (HCV)HIV - Human Immunodeficiency VirusHepatitis B Virus (HBV)Hepatitis CImplementation ScienceIncarcerationInjection Drug Use

Phase 2

Utilization of Hepatitis C Positive Kidneys in Negative Recipients

CompletedNCT03801707

Ohio State UniversityHCV, Hepatitis C, Kidney Transplant

Start: 2019-03-22End: 2021-04-30Updated: 2023-09-13

Phase 4

Implementing Low-Barrier HCV Treatment in a Jail Setting

RecruitingNCT06953479

LifespanHEPATITIS C (HCV), Implementation Science, Incarceration +1

Start: 2025-06-11End: 2027-08-01Target: 40Updated: 2026-02-27

Combating Related Epidemics in HCV

Not yet recruitingNCT07560046

Duke UniversityHepatitis B Virus (HBV), HEPATITIS C (HCV), HIV - Human Immunodeficiency Virus

Start: 2026-08-01End: 2030-12-30Target: 1280Updated: 2026-05-05

Related Papers

MINMON-J: a hybrid implementation pilot study evaluating a low-barrier hepatitis C treatment model in a jail setting

BMJ Open2025-09-011 citations